Ashar Bimal H, Miller Redonda G, Pichard Carmen P, Levine Rachel, Wright Scott M
Division of General Internal Medicine, Johns Hopkins University, 601 N. Caroline Street, #7143, Baltimore, MD 21287, USA.
J Community Health. 2008 Feb;33(1):22-30. doi: 10.1007/s10900-007-9063-7.
The Dietary Supplement Health and Education Act (DSHEA) permits manufacturers to sell products without providing pre-market evidence of safety or efficacy. One fundamental reason for the passage of the DSHEA was to empower consumers to make their own choices, free from governmental restriction. Yet, little is known about the public's understanding of the supplement regulatory process. We undertook a study to assess patients' knowledge regarding governmental oversight of product marketing and advertising. A survey of 300 adult patients from the Baltimore Metropolitan area was administered after showing participants an advertisement for a dietary supplement. Patients were asked questions regarding their understanding of federal regulation of the advertised product. A total of 52% of respondents were unaware that the dietary supplement had not been approved by the government while 63% were unaware that the advertisement for that supplement had not been pre-approved. Factors associated with a lack of understanding of the product approval process included lower education level (OR 2.52; 95% CI 1.52-4.19) and non-Caucasian race (OR 1.99; 95% CI 1.17-3.36). Lower education level was also associated with confusion regarding the advertisement approval process (OR 2.60; 95% CI 1.48-4.57). Based on these results, patients seem unclear about the government's role in the regulation of dietary supplements. Educational efforts should be geared towards clarifying these issues.
《膳食补充剂健康与教育法》(DSHEA)允许制造商在不提供上市前安全性或有效性证据的情况下销售产品。DSHEA得以通过的一个根本原因是赋予消费者自主选择权,使其免受政府限制。然而,对于公众对补充剂监管过程的理解却知之甚少。我们开展了一项研究,以评估患者对政府对产品营销和广告监管的了解情况。在向参与者展示一则膳食补充剂广告后,对来自巴尔的摩都会区的300名成年患者进行了调查。询问患者对所宣传产品的联邦监管的理解相关问题。共有52%的受访者不知道该膳食补充剂未获政府批准,而63%的人不知道该补充剂的广告未预先获批。与对产品批准过程缺乏理解相关的因素包括教育水平较低(比值比2.52;95%置信区间1.52 - 4.19)和非白种人种族(比值比1.99;95%置信区间1.17 - 3.36)。教育水平较低还与对广告批准过程的困惑有关(比值比2.60;95%置信区间1.48 - 4.57)。基于这些结果,患者似乎不清楚政府在膳食补充剂监管中的作用。应开展教育工作以澄清这些问题。